Ledipasvir and Sofosbuvir
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
Ledipasvir and Sofosbuvir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $1098.94 to $1098.94 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$1098.94 – $1098.94
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Gilead Sciences, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Hepatitis C Virus NS5A Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing LEDIPASVIR AND SOFOSBUVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HARVONI 90-400 MG TABLET | $1098.9375 per EA | — |
Frequently Asked Questions
How many Ledipasvir and Sofosbuvir products are on the market?
The Ledipasvir and Sofosbuvir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Ledipasvir and Sofosbuvir?
NADAC reference prices for Ledipasvir and Sofosbuvir range from $1098.9375 to $1098.9375 per EA.
Which manufacturers make Ledipasvir and Sofosbuvir?
1 manufacturer lists Ledipasvir and Sofosbuvir in NADAC. Ranked by number of NDCs, the largest are Gilead Sciences, Inc. (1).